Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, 903-0125, Okinawa, Japan.
BMC Musculoskelet Disord. 2023 Jul 19;24(1):593. doi: 10.1186/s12891-023-06730-1.
F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG-PET/CT) is useful for assessing location, metastasis, staging, and recurrence of malignant tumors. Tenosynovial giant cell tumor (TSGCT) is a benign tumor; however, some studies have reported that TSGCTs have a high uptake of FDG. Few studies have reported on the detailed evaluation of TSGCT using F-FDG-PET/CT. The purpose of the current study is to evaluate the image characteristics and locations, particularly where possible, with or without, extra-articular invasion from TSGCT of the knee in F-FDG-PET/CT could occur.
We retrospectively reviewed the patients with TSGCT who were diagnosed pathologically either by biopsy or surgical specimen. Furthermore, we evaluated the difference of the maximum standardized uptake value (SUVmax) between diffused TSGCT with extra-articular invasion and TSGCT with intra-articular localization in the knee.
The study consisted of 20 patients with TSGCT. The mean SUVmax of TSGCT was 12.0 ± 6.50. There were five patients with TSGCT arising in the knee with extra-articular invasion and six with TSGCT with intra-articular localization. The mean SUVmax of TSGCT with extra-articular invasion and those with intra-articular localization were 14.3 ± 6.00 and 5.94 ± 3.89, respectively. TSGCT with extra-articular invasion had significantly higher SUVmax than TSGCT with intra-articular localization (p < 0.05).
TSGCT revealed high FDG uptake. Furthermore, SUVmax was higher in diffused TSGCT with extra-articular invasion than in intra-articular localized TSGCT; this may reflect its local aggressiveness.
氟-18 脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG-PET/CT)可用于评估恶性肿瘤的位置、转移、分期和复发。腱鞘巨细胞瘤(TSGCT)是一种良性肿瘤;然而,一些研究报告称 TSGCT 对 FDG 有很高的摄取率。很少有研究报告 F-FDG-PET/CT 对 TSGCT 的详细评估。本研究旨在评估膝关节 TSGCT 的 F-FDG-PET/CT 图像特征和位置,特别是在可能的情况下,评估 TSGCT 是否存在关节外侵犯。
我们回顾性分析了经病理活检或手术标本诊断为 TSGCT 的患者。此外,我们评估了膝关节内 TSGCT 伴或不伴关节外侵犯时最大标准化摄取值(SUVmax)的差异。
本研究共纳入 20 例 TSGCT 患者。TSGCT 的平均 SUVmax 为 12.0±6.50。有 5 例膝关节 TSGCT 伴关节外侵犯,6 例膝关节 TSGCT 伴关节内定位。伴关节外侵犯的 TSGCT 和伴关节内定位的 TSGCT 的平均 SUVmax 分别为 14.3±6.00 和 5.94±3.89。伴关节外侵犯的 TSGCT 的 SUVmax 明显高于伴关节内定位的 TSGCT(p<0.05)。
TSGCT 显示出高 FDG 摄取率。此外,伴关节外侵犯的弥漫性 TSGCT 的 SUVmax 高于关节内定位的 TSGCT;这可能反映了其局部侵袭性。